3218 logo

Universal Vision Biotechnology Co., Ltd. Stock Price

TPEX:3218 Community·NT$11.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

3218 Share Price Performance

NT$137.00
-72.00 (-34.45%)
NT$137.00
-72.00 (-34.45%)
Price NT$137.00

3218 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet 6 star dividend payer.

0 Risks
2 Rewards

Universal Vision Biotechnology Co., Ltd. Key Details

NT$4.2b

Revenue

NT$1.7b

Cost of Revenue

NT$2.4b

Gross Profit

NT$1.5b

Other Expenses

NT$960.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
11.34
58.54%
23.04%
0.9%
View Full Analysis

About 3218

Founded
1992
Employees
n/a
CEO
Zhenghong Lu
WebsiteView website
www.uvb.com.tw

Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides administrative and other professional logistics support services for cooperative clinics and eye centers, as well as brand licensing and consulting services. The company offers its products through its self-operated eyeglasses stores. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.

Recent 3218 News & Updates

Recent updates

No updates